Published online January 22, 2007
PEDIATRICS Vol. 119 No. 2 February 2007, pp. e474-e483 (doi:10.1542/10.1542/peds.2006-1434)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kallinich, T. Articles by Ozen, S. Search for Related Content PubMed PubMed Citation Articles by Kallinich, T. Articles by Ozen, S. Related Collections Infectious Disease & Immunity Social Bookmarking                         What's this?

REVIEW ARTICLE

Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement

Tilmann Kallinich, MD^a, Dieter Haffner, MD^b, Tim Niehues, MD^c, Kristina Huss, MD^d, Elke Lainka, MD^e, Ulrich Neudorf, MD^e, Christof Schaefer, MD^f, Silvia Stojanov, MD^d, Christian Timmann, MD^g, Rolf Keitzer, MD^a, Huri Ozdogan, MD^h and Seza Ozen, MDⁱ

^a Department of Pediatric Pneumology and Immunology, Charité Campus Virchow-Klinikum, Universitaetsmedizin Berlin, Berlin, Germany
^b Department of Pediatrics, University Hospital Rostock, Rostock, Germany
^c Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
^d Department of Infectious Diseases and Immunology, Children's University Hospital, Munich, Germany
^e Department of Pediatrics, University of Duisburg-Essen, Duisburg, Germany
^f Pharmakovigilanz und Beratungszentrum für Embryonaltoxikologie, Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Berlin, Germany
^g Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
^h Cerrahpasa Faculty of Medicine, University of Istanbul, Cerrahpasa, Turkey
ⁱ Department of Pediatric Nephrology and Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.

---

Key Words: familial Mediterranean fever • colchicine • evidence-based guidelines • treatment

Abbreviations: FMF—familial Mediterranean fever • SAA—serum amyloid A • GFR—glomerular filtration rate

---

Accepted Sep 14, 2006.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Bajaj and J. Jimenez Intermittent Fevers, Abdominal Pain, and Elevated Inflammatory Markers Clinical Pediatrics, June 1, 2009; 48(5): 561 - 563. [PDF]

				S Ozen, N Aktay, E Lainka, A Duzova, A Bakkaloglu, and T Kallinich Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease Ann Rheum Dis, February 1, 2009; 68(2): 246 - 248. [Abstract] [Full Text] [PDF]